ada.enesco, Author at European Medical Journal

Climatic Factors Drive Oropouche Virus Spread Across Latin America

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

Nasal Epithelial Assays Predict Cystic Fibrosis Clinical Outcomes

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Eosinophil Count and FeNO Enhance Asthma Risk Prediction

Blood eosinophil count and fractional exhaled nitric oxide significantly enhance prognostic assessment of asthma attack risk.

WHO Pathogen List Refines AMR Research Priorities

The WHO has released its updated 2024 Bacterial Priority Pathogens List, offering clinicians and researchers a more granular framework for guiding antimicrobial stewardship.

Single RSV Vaccine Dose Protects Older Adults Across Three Seasons

A single dose of the RSVPreF3 OA vaccine offers strong protection against RSV-related lower respiratory tract disease in older adults across three seasons.

Sharp Rise in Paediatric Invasive Group A Streptococcal Infections

Invasive group A streptococcal infections in children have significantly increased in Ontario over recent years, particularly following the COVID-19 pandemic.

ESCMID Global 2025: AI Lung Ultrasound Outperforms Experts in Tuberculosis Diagnosis

An AI-powered lung ultrasound tool has outperformed human experts in diagnosing pulmonary tuberculosis, offering a fast, accessible, and sputum-free solution.

ESCMID Global 2025: Breath-Based Bacterial Test Shows Real-Time Diagnostic Promise

A novel breath test that identifies bacterial infections may offer clinicians a rapid, non-invasive diagnostic and monitoring tool, according to findings presented at ESCMID Global 2025.

ESCMID Global 2025: Three Million Child Deaths Tied to AMR in 2022

More than 3 million children worldwide died from antimicrobial resistance-related infections in 2022, according to a landmark study presented at ESCMID Global 2025.

Revised Guidelines Highlight Wilson’s Disease Diagnostic Advances

While effective therapies exist, challenges remain in managing acute liver failure, where transplantation may be life-saving.